Evidence map›Paper›PMID 20562910›Full record

ArticleOncogene2010

Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

J J Bower, G F Karaca, Y Zhou, D A Simpson, M Cordeiro-Stone, W K Kaufmann

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Topoisomerase IIα is essential for maintenance of mitotic chromosome structure.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
  13. Review
  14. MCPH1 is essential for cellular adaptation to the GFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  15. Article
  16. Gene expression ofCancer management and research · 2018
    Article
  17. A Topology-Centric View on Mitotic Chromosome Architecture.International journal of molecular sciences · 2017
    Review
  18. Non-Catalytic Roles of the Topoisomerase IIα C-Terminal Domain.International journal of molecular sciences · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J J BowerDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
G F Karaca
Y Zhou
D A Simpson
M Cordeiro-Stone
W K Kaufmann
University of North Carolina at Chapel Hill · USCenter for Environmental Health · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
G2 CHECKPOINT FUNCTION IN HUMAN FIBROBLASTSR01CA081343 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMANN, WILLIAM K · 1999 to 2007
$1.9M
Regulation of the Topoiomerase II-Dependent G2 Decatenation CheckpointF32CA134155 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOWER, JACQUELYN J · 2008 to 2008
$50k
NCI NIH HHS 1F32CA134155-0NCI NIH HHS CA81343NCI NIH HHS F32 CA134155NCI NIH HHS R01 CA081343NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P30-ES10126
6 · The paper itself

Abstract

Topoisomerase IIalpha (topoIIalpha) is an essential mammalian enzyme that topologically modifies DNA and is required for chromosome segregation during mitosis. Previous research suggests that inhibition of topoII decatenatory activity triggers a G(2) checkpoint response, which delays mitotic entry because of insufficient decatenation of daughter chromatids. Here we examine the effects of both topoIIalpha and topoIIbeta on decatenatory activity in cell extracts, DNA damage and decatenation G(2) checkpoint function, and the frequencies of p16(INK4A) allele loss and gain. In diploid human fibroblast lines, depletion of topoIIalpha by small-interfering RNA was associated with severely reduced decatenatory activity, delayed progression from G(2) into mitosis and insensitivity to G(2) arrest induced by the topoII catalytic inhibitor ICRF-193. Furthermore, interphase nuclei of topoIIalpha-depleted cells showed increased frequencies of losses and gains of the tumor suppressor genetic locus p16(INK4A). This study shows that the topoIIalpha protein is required for decatenation G(2) checkpoint function, and inactivation of decatenation and the decatenation G(2) checkpoint leads to abnormal chromosome segregation and genomic instability.

Indexed as

Genomic InstabilityAntigens, NeoplasmCell CycleCell Cycle ProteinsChromatidsChromosome SegregationDiketopiperazinesDNADNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Topoisomerases, Type IIFibroblastsG2 PhaseGenes, p16HumansMitosis4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedioneAntigens, NeoplasmCell Cycle ProteinsDiketopiperazinesDNADNA-Binding ProteinsDNA Topoisomerases, Type IIPiperazinesTopoisomerase II Inhibitors

Identifiers

PMID20562910
PMCPMC2928865
OpenAlexW2170235750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.